Aytu BioPharma, Inc. (AYTU)

USD 1.03

(1.97%)

Total Liabilities Summary of Aytu BioPharma, Inc.

  • Aytu BioPharma, Inc.'s latest annual total liabilities in 2024 was 90.37 Million USD , down -6.93% from previous year.
  • Aytu BioPharma, Inc.'s latest quarterly total liabilities in 2024 Q4 was 90.37 Million USD , down -7.86% from previous quarter.
  • Aytu BioPharma, Inc. reported annual total liabilities of 97.1 Million USD in 2023, up 6.09% from previous year.
  • Aytu BioPharma, Inc. reported annual total liabilities of 91.53 Million USD in 2022, down -28.55% from previous year.
  • Aytu BioPharma, Inc. reported quarterly total liabilities of 98.08 Million USD for 2024 Q3, down -0.32% from previous quarter.
  • Aytu BioPharma, Inc. reported quarterly total liabilities of 98.39 Million USD for 2024 Q2, down -2.31% from previous quarter.

Annual Total Liabilities Chart of Aytu BioPharma, Inc. (2024 - 2007)

Historical Annual Total Liabilities of Aytu BioPharma, Inc. (2024 - 2007)

Year Total Liabilities Total Liabilities Growth
2024 90.37 Million USD -6.93%
2023 97.1 Million USD 6.09%
2022 91.53 Million USD -28.55%
2021 128.1 Million USD 121.55%
2020 57.82 Million USD 109.24%
2019 27.63 Million USD 261.9%
2018 7.63 Million USD -30.58%
2017 10.99 Million USD -22.86%
2016 14.25 Million USD 446.2%
2015 2.61 Million USD -60.73%
2014 6.64 Million USD 5414.78%
2013 120.52 Thousand USD 46.33%
2012 82.36 Thousand USD 40.96%
2011 58.43 Thousand USD -29.34%
2010 82.69 Thousand USD 49.18%
2009 55.43 Thousand USD 15.21%
2008 48.11 Thousand USD 17.74%
2007 40.86 Thousand USD 0.0%

Peer Total Liabilities Comparison of Aytu BioPharma, Inc.

Name Total Liabilities Total Liabilities Difference
Journey Medical Corporation 56.49 Million USD -59.966%
Safety Shot Inc 3.89 Million USD -2222.147%
Bright Green Corporation 6.43 Million USD -1303.814%
Alvotech 1.88 Billion USD 95.199%
Aquestive Therapeutics, Inc. 163.9 Million USD 44.859%
Cosmos Health Inc. 30.25 Million USD -198.749%
Dynavax Technologies Corporation 375.02 Million USD 75.9%
Embecta Corp. 2.03 Billion USD 95.561%
Esperion Therapeutics, Inc. 660.79 Million USD 86.323%
Intra-Cellular Therapies, Inc. 136.87 Million USD 33.968%
Pacira BioSciences, Inc. 704.25 Million USD 87.167%
PainReform Ltd. 2.69 Million USD -3258.566%
Sunshine Biopharma, Inc. 6.13 Million USD -1372.067%
SCYNEXIS, Inc. 55.45 Million USD -62.992%
China SXT Pharmaceuticals, Inc. 9.19 Million USD -882.742%
Alpha Teknova, Inc. 38.55 Million USD -134.44%
ANI Pharmaceuticals, Inc. 471.67 Million USD 80.839%
Collegium Pharmaceutical, Inc. 947.87 Million USD 90.465%
Sunshine Biopharma, Inc. 6.13 Million USD -1372.067%
Procaps Group, S.A. 462.06 Million USD 80.44%
Theratechnologies Inc. 98.63 Million USD 8.374%
Harrow Health, Inc. 241.75 Million USD 62.615%
Sonoma Pharmaceuticals, Inc. 8.75 Million USD -932.195%
Biofrontera Inc. 23.13 Million USD -290.592%
DURECT Corporation 30.4 Million USD -197.241%
Supernus Pharmaceuticals, Inc. 487.46 Million USD 81.459%
Cronos Group Inc. 43.73 Million USD -106.646%
OptiNose, Inc. 194.33 Million USD 53.493%
Ironwood Pharmaceuticals, Inc. 817.36 Million USD 88.943%
Kala Pharmaceuticals, Inc. 48.44 Million USD -86.56%
RedHill Biopharma Ltd. 20.97 Million USD -330.825%
Organogenesis Holdings Inc. 181.36 Million USD 50.167%
Guardion Health Sciences, Inc. 3.77 Million USD -2295.965%
Cumberland Pharmaceuticals Inc. 52.51 Million USD -72.097%
Radius Health, Inc. 804.29 Million USD 88.763%
Universe Pharmaceuticals INC 13.75 Million USD -557.095%
ProPhase Labs, Inc. 42.54 Million USD -112.437%
Phibro Animal Health Corporation 725.54 Million USD 87.543%
Procaps Group S.A. 462.06 Million USD 80.44%
TherapeuticsMD, Inc. 14.02 Million USD -544.551%
Viatris Inc. 27.21 Billion USD 99.668%
Rockwell Medical, Inc. 30.88 Million USD -192.659%
SIGA Technologies, Inc. 57.97 Million USD -55.887%
Tilray Brands, Inc. 892.11 Million USD 89.869%
Lifecore Biomedical, Inc. 219.8 Million USD 58.881%
Shineco, Inc. 47.6 Million USD -89.865%
PetIQ, Inc. 645.22 Million USD 85.993%
Regencell Bioscience Holdings Limited 219.51 Thousand USD -41072.692%
Incannex Healthcare Limited 5.83 Million USD -1450.24%
Neurocrine Biosciences, Inc. 1.01 Billion USD 91.134%
Alimera Sciences, Inc. 107.35 Million USD 15.812%
Silver Spike Investment Corp. 3 Million USD -2902.793%
Assertio Holdings, Inc. 148.41 Million USD 39.104%
Shuttle Pharmaceuticals Holdings, Inc. 1.89 Million USD -4666.913%
Petros Pharmaceuticals, Inc. 21.31 Million USD -324.001%
Clever Leaves Holdings Inc. 7.02 Million USD -1186.351%
Cyclo Therapeutics, Inc. 8.49 Million USD -964.468%
Avadel Pharmaceuticals plc 173.38 Million USD 47.874%
Hempacco Co., Inc. 18.82 Million USD -380.167%
Talphera, Inc. 6.29 Million USD -1336.868%
Alvotech 1.88 Billion USD 95.199%
Eagle Pharmaceuticals, Inc. 172.6 Million USD 47.637%
Lantheus Holdings, Inc. 835.25 Million USD 89.179%
Currenc Group, Inc. 177.67 Million USD 49.133%
Kamada Ltd. 109.96 Million USD 17.814%
Indivior PLC 1.95 Billion USD 95.368%
Evoke Pharma, Inc. 9.64 Million USD -836.756%
Flora Growth Corp. 17.22 Million USD -424.788%
Cyclo Therapeutics, Inc. 8.49 Million USD -964.468%
Evolus, Inc. 209.68 Million USD 56.898%
HUTCHMED (China) Limited 536.38 Million USD 83.15%
Amphastar Pharmaceuticals, Inc. 873.49 Million USD 89.653%
Akanda Corp. 12.66 Million USD -613.393%